Ngā kupu hautoa kōpae
Tohutoro APA (7th ed.)
Cathomas, R., Petrausch, U., Omlin, A., Hayoz, S., Spahn, M., Schneider, M., . . . Rothschild, S. (2023). Novel sequential treatment strategy for patients with muscle-invasive bladder cancer (MIBC): Intravesical recombinant BCG, followed by neoadjuvant chemoimmunotherapy, radical cystectomy plus pelvic lymphadenectomy and adjuvant immunotherapy – protocol of a multicentre, single arm phase 2 trial (SAKK 06/19). BMJ Publishing Group.
I tāruatia paitia ki te papatopenga
Kua rahua te tārua ki te papatopenga
Tohutoru Kātū Chicago (17th ed.)
Cathomas, Richard, Ulf Petrausch, Aurelius Omlin, Stefanie Hayoz, Martin Spahn, Martina Schneider, Cyrill A. Rentsch, me Sacha Rothschild. Novel Sequential Treatment Strategy for Patients with Muscle-invasive Bladder Cancer (MIBC): Intravesical Recombinant BCG, Followed by Neoadjuvant Chemoimmunotherapy, Radical Cystectomy Plus Pelvic Lymphadenectomy and Adjuvant Immunotherapy – Protocol of a Multicentre, Single Arm Phase 2 Trial (SAKK 06/19). BMJ Publishing Group, 2023.
I tāruatia paitia ki te papatopenga
Kua rahua te tārua ki te papatopenga
Tohutoro MLA (9th ed.)
Cathomas, Richard, et al. Novel Sequential Treatment Strategy for Patients with Muscle-invasive Bladder Cancer (MIBC): Intravesical Recombinant BCG, Followed by Neoadjuvant Chemoimmunotherapy, Radical Cystectomy Plus Pelvic Lymphadenectomy and Adjuvant Immunotherapy – Protocol of a Multicentre, Single Arm Phase 2 Trial (SAKK 06/19). BMJ Publishing Group, 2023.
I tāruatia paitia ki te papatopenga
Kua rahua te tārua ki te papatopenga
Kia tūpato: Kāore pea ēnei kupu hautoa i te ōrite pū 100%.